Compare Advanced Micro Devices (AMD) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Advanced Micro DevicesTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Advanced Micro Devices vs Neurocrine Biosciences Inc — how do they compare? Advanced Micro Devices trades at $532.87 (market cap $909.70B), while Neurocrine Biosciences Inc trades at $174.37 (market cap $17.82B). The key difference: Advanced Micro Devices is far larger — about 51× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.

	AMD	NBIX
Market Cap	$909.70B	$17.82B
Sector	Technology	Health
52-Week High	$580.91	$180.55
52-Week Low	$146.24	$123.10
Enterprise Value	$901.22B	$16.91B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Advanced Micro Devices

AMD trades at $557.89, up 2.04% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth, with 2025 revenue reaching $34.64 billion and net income surging to $4.34 billion, though valuation ratios like P/E of 185.96 indicate premium pricing. Recent earnings beats and positive AI-driven news fuel investor optimism.

Outlook remains positive due to AI demand and earnings momentum, but high valuations and intense competition pose risks. Analyst consensus is strongly bullish with a $508.24 price target, though the stock trades above this, suggesting near-term caution amid long-term growth potential.

Neurocrine Biosciences Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMD

Stocks fall and oil nears $80 as Trump blocks Strait of Hormuz, raising energy fears and tech jitters.New York Post · 9 hours agoBearish TSMC's limited chip packaging capacity may slow AMD's stock rally despite strong demand.Forbes · 13 hours agoNeutral AI chip stocks NVDA, AMD, and INTC may open lower but show support levels for potential rebounds.FXEmpire · 14 hours agoNeutral View details →

NBIX

Neurocrine shares jump 27% this year on strong sales and pipeline growth.FXEmpire · 3 days agoBullish Neurocrine Biosciences schedules Q2 2026 earnings call for July 30PRNewsWire · 4 days agoNeutral View details →

About Advanced Micro Devices

Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.